1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Czech Republic 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD Actual,
2003-2017 11
3.3 Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2010 12
3.4 Diabetes Care Devices Market, Czech Republic, Category Contribution (%),
2010 13
3.5 Diabetes Care Devices, Czech Republic, Category Volume (Units), 2003-2017 20
3.6 Diabetes Care Devices, Czech Republic, Company share (2009-2010) 23
4 Glucose Monitoring In Czech Republic 25
4.1 Glucose Monitoring, Market Segmentation 25
4.2 Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2010 26
4.3 Glucose Monitoring Market, Czech Republic, Segment Contribution (%), 2010 27
4.4 Glucose Monitoring Overall Revenue (2003-2017) 28
4.4.1 Blood Glucose Meters Revenue (2003-2017) 32
4.5 Glucose Monitoring Overall Volume (2003-2017) 36
4.5.1 Blood Glucose Meters Volume (2003-2017) 39
4.6 Glucose Monitoring Average Price (2003-2017) 42
4.7 Glucose Monitoring Distribution Share (2009-2010) 43
4.8 Glucose Monitoring, Czech Republic, Company Share (2009-2010) 44
5 Insulin Delivery In Czech Republic 46
5.1 Insulin Delivery, Market Segmentation 46
5.2 Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2010 47
5.3 Insulin Delivery Market, Czech Republic, Segment Contribution (%), 2010 48
5.4 Insulin Delivery Overall Revenue (2003-2017) 49
5.4.1 Insulin Pens Revenue (2003-2017) 53
5.4.2 Insulin Pumps Revenue (2003-2017) 57
5.5 Insulin Delivery Overall Volume (2003-2017) 59
5.5.1 Insulin Pens Volume (2003-2017) 63
5.5.2 Insulin Pumps Volume (2003-2017) 66
5.6 Insulin Delivery Average Price (2003-2017) 68
5.7 Insulin Delivery Distribution Share (2009-2010) 69
5.8 Insulin Delivery, Czech Republic, Company Share (2009-2010) 70
6 Overview of Key Companies in Czech Republic Diabetes Care Devices Market 72
6.1 F. Hoffmann-La Roche Ltd. 72
6.1.1 Company Overview 72
6.1.2 Share in the Czech Republic Diabetes Care Devices Market 72
6.2 LifeScan, Inc. 73
6.2.1 Company Overview 73
6.2.2 Share in the Czech Republic Diabetes Care Devices Market 73
6.3 Sanofi 74
6.3.1 Company Overview 74
6.3.2 Share in the Czech Republic Diabetes Care Devices Market 74
6.4 Eli Lilly and Company 75
6.4.1 Company Overview 75
6.4.2 Share in the Czech Republic Diabetes Care Devices Market 75
6.5 Novo Nordisk A/S 76
6.5.1 Company Overview 76
6.5.2 Share in the Czech Republic Diabetes Care Devices Market 76
6.6 Bayer HealthCare AG 77
6.6.1 Company Overview 77
6.6.2 Share in the Czech Republic Diabetes Care Devices Market 77
6.7 Abbott Laboratories 78
6.7.1 Company Overview 78
6.8 Becton, Dickinson and Company 78
6.8.1 Company Overview 78
6.9 Medtronic, Inc. 79
6.9.1 Company Overview 79
6.10 Ypsomed Holding AG 79
6.10.1 Company Overview 79
6.11 NIPRO CORPORATION 79
6.11.1 Company Overview 79
6.12 Terumo Corporation 80
6.12.1 Company Overview 80
6.13 Animas Corporation 80
6.13.1 Company Overview 80
7 Diabetes Care Devices Market Pipeline Products 81
8 Financial Deals Landscape 85
8.1 Partnerships 85
8.1.1 Trinity Biotech Enters Into Distribution Agreement With A. Menarini
Diagnostics 85
9 Recent Developments 86
9.1 Strategy and Business Planning 86
9.1.1 Apr 04, 2011: Sanofi-aventiss European Generic Pharmaceuticals Businesses
To Operate Under Unified Brand Name Zentiva 86
10 Appendix 87
10.1 Definitions of Markets Covered in the Report 88
10.1.1 Diabetes Care Devices 88
10.2 Research Methodology 91
10.3 Secondary Research 91
10.4 Primary Research 92
10.5 Models 92
10.6 Forecasts 93
10.7 Expert Panels 93
10.8 GlobalData Consulting 93
10.9 Currency Conversion 94
10.10 Contact Us 94
10.11 Disclaimer 94
1.1 List of Tables
Table 1: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, 2003-2017 11
Table 2: Diabetes Care Devices Market, Czech Republic, Category Contribution
(%), 2010 13
Table 3: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis,
2003-2017 15
Table 4: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, Historic, 2003-2010 17
Table 5: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, Forecast, 2010-2017 19
Table 6: Diabetes Care Devices, Czech Republic, Category Volume (Units),
2003-2017 20
Table 7: Diabetes Care Devices, Czech Republic, Category Volume (Units),
Historic, 2003-2010 21
Table 8: Diabetes Care Devices, Czech Republic, Category Volume (Units),
Forecast, 2010-2017 22
Table 9: Diabetes Care Devices, Czech Republic, Company share by Revenue ($m),
USD Actual, 2009-2010 24
Table 10: Glucose Monitoring Market, Czech Republic, Segment Contribution (%),
2010 27
Table 11: Glucose Monitoring, Czech Republic, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 29
Table 12: Glucose Monitoring, Czech Republic, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 31
Table 13: Blood Glucose Meters, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 33
Table 14: Blood Glucose Meters, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 35
Table 15: Glucose Monitoring, Czech Republic, Volume (Units) by Segment,
Historic, 2003-2010 37
Table 16: Glucose Monitoring, Czech Republic, Volume (Units) by Segment,
Forecast, 2010-2017 38
Table 17: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment,
Historic, 2003-2010 40
Table 18: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 41
Table 19: Glucose Monitoring, Czech Republic, Average Price ($), Historic,
2003-2010 42
Table 20: Glucose Monitoring, Czech Republic, Average Price ($), Forecast,
2010-2017 42
Table 21: Glucose Monitoring, Czech Republic, Distribution Share by Revenue
($m), USD Actual, 2009-2010 43
Table 22: Glucose Monitoring, Czech Republic, Company Share by Revenue ($m), USD
Actual 2009-2010 45
Table 23: Insulin Delivery Market, Czech Republic, Segment Contribution (%),
2010 48
Table 24: Insulin Delivery, Czech Republic, Revenue ($m), USD Actual by Segment,
Historic, 2003-2010 50
Table 25: Insulin Delivery, Czech Republic, Revenue ($m), USD Actual by Segment,
Forecast, 2010-2017 52
Table 26: Insulin Pens, Czech Republic, Revenue ($m), USD Actual by Sub-Segment,
Historic, 2003-2010 54
Table 27: Insulin Pens, Czech Republic, Revenue ($m), USD Actual by Sub-Segment,
Forecast, 2010-2017 56
Table 28: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue
($m), USD Actual, Historic, 2003-2010 57
Table 29: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue
($m), USD Actual, Forecast, 2010-2017 58
Table 30: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Historic,
2003-2010 60
Table 31: Insulin Delivery, Czech Republic, Volume (Units) by Segment, Forecast,
2010-2017 62
Table 32: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Historic,
2003-2010 64
Table 33: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment, Forecast,
2010-2017 65
Table 34: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume
(Units), Historic, 2003-2010 66
Table 35: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume
(Units), Forecast, 2010-2017 67
Table 36: Insulin Delivery, Czech Republic, Average Price ($), Historic,
2003-2010 68
Table 37: Insulin Delivery, Czech Republic, Average Price ($), Forecast,
2010-2017 68
Table 38: Insulin Delivery, Czech Republic, Distribution Share by Revenue ($m),
USD Actual, 2009-2010 69
Table 39: Insulin Delivery, Czech Republic, Company Share by Revenue ($m), USD
Actual 2009-2010 71
Table 40: Diabetes Care Devices Market Pipeline Products 81
Table 41: Trinity Biotech Enters Into Distribution Agreement With A. Menarini
Diagnostics 85
Table 42: USD to Local Currency, Czech Republic, Average Actual Rate 2003-2010
94
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, 2003-2017 11
Figure 3: Diabetes Care Devices Market, Czech Republic, Revenue Mix ($m), 2010
12
Figure 4: Diabetes Care Devices Market, Czech Republic, Category Contribution
(%), 2010 13
Figure 5: Diabetes Care Devices, Czech Republic, Cross-Segment Analysis,
2003-2017 14
Figure 6: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, Historic, 2003-2010 16
Figure 7: Diabetes Care Devices, Czech Republic, Overall Revenue ($m), USD
Actual, Forecast, 2010-2017 18
Figure 8: Diabetes Care Devices, Czech Republic, Category Volume (Units),
2003-2017 20
Figure 9: Diabetes Care Devices, Czech Republic, Category Volume (Units),
Historic, 2003-2010 21
Figure 10: Diabetes Care Devices, Czech Republic, Category Volume (Units),
Forecast, 2010-2017 22
Figure 11: Diabetes Care Devices, Czech Republic, Company share (%), 2010 23
Figure 12: Glucose Monitoring, Market Segmentation 25
Figure 13: Glucose Monitoring Market, Czech Republic, Revenue Mix ($m), 2010 26
Figure 14: Glucose Monitoring Market, Czech Republic, Segment Contribution (%),
2010 27
Figure 15: Glucose Monitoring, Czech Republic, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 28
Figure 16: Glucose Monitoring, Czech Republic, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 30
Figure 17: Blood Glucose Meters, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 32
Figure 18: Blood Glucose Meters, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 34
Figure 19: Glucose Monitoring, Czech Republic, Volume (Units) by Segment,
Historic, 2003-2010 36
Figure 20: Glucose Monitoring, Czech Republic, Volume (Units) by Segment,
Forecast, 2010-2017 38
Figure 21: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment,
Historic, 2003-2010 39
Figure 22: Blood Glucose Meters, Czech Republic, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 41
Figure 23: Glucose Monitoring, Czech Republic, Company Share (%), 2010 44
Figure 24: Insulin Delivery, Market Segmentation 46
Figure 25: Insulin Delivery Market, Czech Republic, Revenue Mix ($m), 2010 47
Figure 26: Insulin Delivery Market, Czech Republic, Segment Contribution (%),
2010 48
Figure 27: Insulin Delivery, Czech Republic, Revenue ($m), USD Actual by
Segment, Historic, 2003-2010 49
Figure 28: Insulin Delivery, Czech Republic, Revenue ($m), USD Actual by
Segment, Forecast, 2010-2017 51
Figure 29: Insulin Pens, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Historic, 2003-2010 53
Figure 30: Insulin Pens, Czech Republic, Revenue ($m), USD Actual by
Sub-Segment, Forecast, 2010-2017 55
Figure 31: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue
($m), USD Actual, Historic, 2003-2010 57
Figure 32: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Revenue
($m), USD Actual, Forecast, 2010-2017 58
Figure 33: Insulin Delivery, Czech Republic, Volume (Units) by Segment,
Historic, 2003-2010 59
Figure 34: Insulin Delivery, Czech Republic, Volume (Units) by Segment,
Forecast, 2010-2017 61
Figure 35: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment,
Historic, 2003-2010 63
Figure 36: Insulin Pens, Czech Republic, Volume (Units) by Sub-Segment,
Forecast, 2010-2017 65
Figure 37: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume
(Units), Historic, 2003-2010 66
Figure 38: Insulin Pumps (Traditional Insulin Pumps), Czech Republic, Volume
(Units), Forecast, 2010-2017 67
Figure 39: Insulin Delivery, Czech Republic, Company Share (%), 2010 70
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%),Czech Republic Diabetes
Care Devices Market, 2010 72
Figure 41: LifeScan, Inc., Company Share (%),Czech Republic Diabetes Care
Devices Market, 2010 73
Figure 42: Sanofi, Company Share (%),Czech Republic Diabetes Care Devices
Market, 2010 74
Figure 43: Eli Lilly and Company, Company Share (%),Czech Republic Diabetes Care
Devices Market, 2010 75
Figure 44: Novo Nordisk A/S, Company Share (%),Czech Republic Diabetes Care
Devices Market, 2010 76
Figure 45: Bayer HealthCare AG, Company Share (%),Czech Republic Diabetes Care
Devices Market, 2010 77
Companies Mentioned
F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Sanofi
Eli Lilly and Company
Novo Nordisk A/S
Bayer HealthCare AG
Abbott Laboratories
Becton, Dickinson and Company
Medtronic, Inc.
Ypsomed Holding AG
NIPRO CORPORATION
Terumo Corporation
Animas Corporation |
